Department of Military Affairs Tender by Indian Army (10bf98127)

Paroxetin 25 mg Tab,Pioglitazone Hydrochloride 15 mg Tab,Pioglitazone Hydrochloride 30 mg Tab,Polid

Goods
Qty:14.2K
EST Bid: ₹94,178

Tender Timeline

Tender Issue
May 13, 2025 at 10:15 AM

Tender Title: DGLP MEDICINE 28
Reference Number: 10bf98127
Issuing Authority/Department: Department of Military Affairs, Ministry of Defence

The DGLP MEDICINE 28 tender aims to procure various essential medical tablets, specifically targeting the needs within military operations. The project includes the supply of the following medicines:

  • Paroxetin 25 mg Tablets
  • Pioglitazone Hydrochloride 15 mg Tablets
  • Pioglitazone Hydrochloride 30 mg Tablets

The total quantity required is approximately 14,235 units, ensuring a comprehensive range of essential pharmaceuticals is available for personnel in service. The scope of work is to engage suppliers who can provide these specified quantities in a timely and efficient manner, ensuring adherence to quality and safety standards expected in medical supplies.

Scope of Work and Objectives

The primary objectives of this tender are as follows:

  • To secure a reliable supply of medicines crucial for military personnel.
  • To maintain robust quality assurance processes throughout the supply chain.
  • To ensure timely delivery of all listed items to designated military locations.

Eligibility Criteria

To participate in the tender, bidders must meet specific eligibility requirements:

  • Bidders must be registered entities legally allowed to conduct operations related to pharmaceutical supplies.
  • Evidence of prior experience in similar contracts may also be required to demonstrate capability.

Technical Requirements

Suppliers must adhere to strict technical specifications including:

  • Compliance with applicable quality standards for pharmaceutical products.
  • Certifications demonstrating adherence to safety protocols and manufacturing practices.
  • Documentation of testing criteria ensuring product integrity and efficacy.

Financial Requirements

Bidders must submit a detailed financial proposal accompanied by relevant documents, including:

  • Evidence of financial capability to sustain the project duration.
  • Proposals should clearly outline pricing structures, ensuring transparency and competitiveness.

Document Submission Details

Interested parties must submit the required documentation electronically as per the established guidelines within the designated submission portal by the specified deadline. All documents must conform to the accepted formats set by the tendering authority.

Special Provisions

The tender includes special provisions to promote participation from Micro, Small, and Medium Enterprises (MSEs) and startups. These benefits encourage innovative solutions and diversifying the supplier base while observing 'Make in India' policies that emphasize local production.

Evaluation Process

The evaluation of bids will be conducted based on a structured assessment criteria focusing on the following:

  • Compliance with eligibility and qualification requirements.
  • Financial viability and pricing evaluations.
  • Quality and reliability of the proposed products based on technical specifications.

Delivery Locations

Successful suppliers will be contracted to deliver the medicines to designated military facilities as specified by the Department of Military Affairs. Details regarding delivery points will be provided upon finalization of the contract.

Contact Information

Prospective bidders seeking further clarification can contact the Department of Military Affairs through the official communication channels provided in the tender document. All inquiries must be directed to the appropriate contacts listed in the full tender notice for responses.

This tender represents a significant opportunity for eligible suppliers to contribute to the healthcare needs of military personnel and meet the demands of a critical supply chain in the medical sector.


Tender BOQ Items

14 Items
1.

Paroxetin 25 mg Tab

As per pdf

Qty:1800
Unit:no
30
2.

Pioglitazone Hydrochloride 15 mg Tab

As per pdf

Qty:1200
Unit:no
30
3.

Pioglitazone Hydrochloride 30 mg Tab

As per pdf

Qty:3600
Unit:no
30
4.

Polidocanol 3percent 2ml Inj

As per pdf

Qty:30
Unit:amp vial
30
5.

Potassium Chloride 15percent Inj IV amp of 10 ml 1.5gm

As per pdf

Qty:100
Unit:amp vial
30
6.

Povidone Iodine Germicidal Gargle 2percent wobiliquev bott of 100ml

As per pdf

Qty:300
Unit:bott
30
7.

Pralidoxime 500 mgobilique20 ml Inj

As per pdf

Qty:15
Unit:no
30
8.

Prazosin 5 mg sustained releaseobiliqueslow release Tab

As per pdf

Qty:1200
Unit:no
30
9.

Prednislone 10 mg Tab

As per pdf

Qty:1800
Unit:no
30
10.

Premarin 0.625 mg Tab

As per pdf

Qty:1800
Unit:no
30
11.

Propranolol TR 40 mg Tab

As per pdf

Qty:2000
Unit:no
30
12.

Propyl thiouracil 5 mg Tab

As per pdf

Qty:300
Unit:no
30
13.

Protien Powder tin of 400gm Ensure

As per pdf

Qty:60
Unit:bott
30
14.

Purified FSH 75 IU Inj

As per pdf

Qty:30
Unit:amp vial
30

General Information

Item Category
Paroxetin 25 mg Tab , Pioglitazone Hydrochloride 15 mg Tab , Pioglitazone Hydrochloride 30 mg Tab , Polidocanol 3percent 2ml Inj , Potassium Chloride 15percent Inj IV amp of 10 ml 1.5gm , Povidone Iodine Germicidal Gargle 2percent wobiliquev bott of 100ml , Pralidoxime 500 mgobilique20 ml Inj , Prazosin 5 mg sustained releaseobiliqueslow release Tab , Prednislone 10 mg Tab , Premarin 0.625 mg Tab , Propranolol TR 40 mg Tab , Propyl thiouracil 5 mg Tab , Protien Powder tin of 400gm Ensure , Purified FSH 75 IU Inj
Ministry Name
Organisation Name
City

Financial Information

Estimated Bid Value
₹94,178.00
Bid Offer Validity
180 (Days)
Past Performance
10 %
Arbitration Clause
No
Mediation Clause
No

Evaluation and Technical Information

Evaluation Method
Item wise evaluation/
RA Qualification Rule
50% Lowest Priced Technically Qualified Bidders
Inspection Required
Yes
Technical Clarifications Time
2 Days

Tender Documents

4 Documents
GeM-Bidding-7832827.pdfMain Document
BOQ DocumentBOQ BOQ
BOQ DocumentBOQ BOQ
GEM General Terms and Conditions DocumentGEM_GENERAL_TERMS_AND_CONDITIONS

Similar Tenders

View All

Inj. Adrenaline Tartrate 1 ml,Inj. Atropine Sulphate 1 ml,Inj. Artisunate 120 mg,Inj. Aminophyllin

₹600.00
GEM
Goods
Qty:2L
4 Files
Aligarh Muslim University (amu)
ALIGARH, UTTAR PRADESH
Boq › Boql
Inj. Adrenaline Tartrate 1 ml , Inj. Atropine Sulphate 1 ml , Inj. Artisunate 120 mg , Inj. Aminophyllin 10 ml , Inj. Amiodarone Sterile Concentrate 3 ml , Inj. Calcium Gluconate 10 ml , Inj. Dexamethasone 8 mg , Inj. Dopamine Hydrochloride 5 ml , Inj. Diazepam 2 ml , Inj. Dobutamine 5 ml , Inj. Diclofenac Sodium 1 ml , Inj. Ethamsylate 2 ml , Inj. Frusemide 2 ml , Inj. Glycopyrrolate 1 ml , Inj. Hydrocortisone Sodium Succinate 100 mg , Inj. Heparin Sodium 5ml , Inj. Hyoscine Butylbromide 1 ml , Inj. Labetalol 4 ml , Inj. Mephentermine Sulphate 10 ml , Inj. Metoclopramide 2ml , Inj. Magnesium Sulphate 2ml , Inj. Noradrenaline Concentrate 2 ml , Inj. Ondansetron 2 ml , Inj. Ondansetron 4 ml , Inj. Iohexol Solution 50ml , Inj. Oxytocin 1 ml , Inj. Potassium Chloride 10 ml , Inj. Pheniramine Maleate 2 ml , Inj. Phenytoin Sodium 2 ml , Inj. Pantoprazole 40 mg , Inj. Paracetamol 2ml , Inj. Ranitidine Hydrochloride 2ml , Inj. Sodium Bicarbonate 8.4 Percent 25 ml , Tetanus Vaccine Adsorbed 0.5 ml , Inj. Tramadol Hydrochloride 2 ml , Inj. Tranexamic Acid 5 ml , Inj. Torsemide 2ml , Budesonide Nebuliser Suspension 2ml , Ipratropium Nebuliser Solution 2 ml , Ipratropium Bromide and Levosalbutamol Respirator Solution 3ml , Tab. Aceclofenac 100 mg and Paracetamol 325 mg , Tab. Paracetamol 650 mg , Tab. Pantoprazole 40 mg , Eye Drop Cyclopentolate 1 Percent 5 ml , Eye Drop Tropicamide 5 ml , Eye Drop Tropicamide and Phenylephrine Hcl. 5 ml
May 14, 2025
June 5, 2025 at 10:00 AM
View Details

INDOMETHACIN 75MG CAP,NITROGLYCERIN 6.4MG TAB,SILVER SULFADIAZINE OINT,PAROXETINE 12.5MG TAB,CYPROH

₹1,689.00
GEM
Goods
Qty:5.5L
5 Files
Indian Army
JODHPUR, RAJASTHAN
Boq › Boql
INDOMETHACIN 75MG CAP , NITROGLYCERIN 6.4MG TAB , SILVER SULFADIAZINE OINT , PAROXETINE 12.5MG TAB , CYPROHEPTADINE 4 MG TAB , PYRIDOXIN 40 MG TAB , FAROPENEM SODIUM 200 MG TAB , LEVODOPA 100MG Plus CARBIDOPA 25MG TAB , LEVODOPA 100MG Plus CARBIDOPA 10MG TAB , CALCIUM DOBESILATE TAB , NORETHISTERONE 5MG TAB , SYP CYPROHEPTADINE BOTT OF 100 ML , AMLODIPINE 2.5 MG TAB , ACARBOSE 25 MG TAB , AMANTADINE 100MG TAB , AZATHIOPRINE 50 MG TAB , ED CANDIBIOTIC , ED PREDNISOLONE 1 percent , LETROZOLE 2.5MG TAB , MEDROXY PROGESTRONE 10MG TAB , CARBIMAZOLE 20 MG TAB , HALOBETASOL plus SALICYLIC ACID CREAM , MOXIFLOXACIN 400 MG TAB , PIOGLITAZONE 15 MG TAB , RAMIPRIL 2.5MG TAB , TRAMADOL 50 MG CAP , NINTEDANIB 100MG CAP , GEFITINIB 250 MG TAB , MELATONIN 3MG TAB , CINACALCET 30 MG TAB , TRIHEXYPHENIDYL 2MG TAB , NIFEDIPINE 10 MG TAB , LORAZEPAM 1 MG TAB , LITHIUM CARBONATE 300 MG CAP or TAB , INJ LIGNOCAINE 2 percent WITHOUT ADRENALINE , IMIPRAMINE 25 MG TAB , HYDROXYUREA 500 MG CAP , HALOPERIDOL 5MG TAB , CYCLOSPORIN 100MG TAB , CLOBAZAM 5MG TAB , BACLOFEN 10 MG TAB , CARBAMAZEPINE 200 MG TAB , CABERGOLINE 0.5 MG TAB , ACEBROPHYLLINE 100 MG TAB , INJ PEGFILGRASTIM 6MG , FLUOXETINE 20MG TAB , NORMAL SALINE , RL FLUID , ED OLOPATADINE plus KETOROLAC , CLINDAMYCIN 300 MG CAP , MODAFINIL 100 MG TAB , SITAGLIPTIN 50 MG TAB , LAMOTRIGINE 25 MG TAB , CLONAZEPAM 0.25 MG TAB , ACYCLOVIR 400 MG TAB , IBANDRONIC ACID 150MG TAB , CLOMIPRAMINE 25MG TAB , DAPSONE 50MG TAB , ED HOMATROPINE 2 percent W byV , INJ ALBUMIN 20 Percent
May 14, 2025
June 4, 2025 at 3:00 PM
View Details

Frequently Asked Questions

The eligibility requirements for this tender include being a registered legal entity capable of providing pharmaceutical supplies. Bidders must demonstrate relevant experience in handling similar contracts and ensure compliance with local regulations. Additionally, all potential suppliers must maintain the necessary licenses and certifications required for the distribution of medical products.

Bidders are required to adhere to strict technical specifications including compliance with safety and quality standards applicable to the production of pharmaceuticals. Suppliers must provide documentation confirming their manufacturing processes meet quality assurance protocols and detail testing criteria to ensure product efficacy and safety throughout the supply chain.

To participate in the tender, bidders must submit an Earnest Money Deposit (EMD) as specified in the tender documents. The EMD serves as a security measure to indicate the seriousness of the bid. Specific details regarding the amount and submission process can be found within the tender documentation.

All submission methods must comply with the electronic submission requirements outlined in the tender document. Bidders are expected to submit their proposals in PDF or other specified formats, ensuring that all documentation is complete, properly formatted, and submitted by the deadline to avoid disqualification.

This tender includes special provisions to support the participation of MSEs, encouraging them to offer innovative solutions while benefiting from various incentives designed to promote local industries and align with ‘Make in India’ policies. Eligible MSEs may be granted exemptions or additional evaluation credits to foster inclusivity in the bidding process.

Probable Bidders

Companies likely to bid

Get Tender Alerts

Get notifications for similar tenders